{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03439943","recordId":"NCT03439943","peptideSlug":"lixisenatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03439943-lixisenatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03439943.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03439943.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-02-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lixisenatide","submittedDate":"2018-02-13","publishedAt":"2026-08-23","recordId":"NCT03439943","recordSha256":"b99f91e0ca14bc85b72962471864a0270292d6633de889c4c9ff0b0cfcfc3b21","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03439943?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-03-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lixisenatide","submittedDate":"2018-03-16","publishedAt":"2026-08-23","recordId":"NCT03439943","recordSha256":"720f664909fd04c1e2e8204e12fadf0a1bc50d656585c9244504c1990aa4f73e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03439943?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-05-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lixisenatide","submittedDate":"2018-05-30","publishedAt":"2026-08-23","recordId":"NCT03439943","recordSha256":"3956abe7437750cfa10a2b44ece6444bfb09b27aeb0284ed513f91911fa2b800","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03439943?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-07-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lixisenatide","submittedDate":"2018-07-27","publishedAt":"2026-08-23","recordId":"NCT03439943","recordSha256":"20da4688198e1161657aefb1362248f97007ed971f2a12785df1b9763781be52","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03439943?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2020-08-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lixisenatide","submittedDate":"2020-08-24","publishedAt":"2026-08-23","recordId":"NCT03439943","recordSha256":"9665ee4e28a07262f14321bb03e7636662ca25961ef273e2725eeb686fda68ce","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03439943?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2023-06-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lixisenatide","submittedDate":"2023-06-19","publishedAt":"2026-08-23","recordId":"NCT03439943","recordSha256":"9133a8bd2f992f1a225a333d515961450c78f052b0fb10aa5d866a8e7d04021c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03439943?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2025-11-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lixisenatide","submittedDate":"2025-11-21","publishedAt":"2026-08-23","recordId":"NCT03439943","recordSha256":"01123a628d3126db3b0b44b3c588332d910584c8d5971ef5e5ac847930af0869","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03439943?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"36678617ef78fc349b3536b48c42a2896c1cbea47e02b06fe74ae2bbc6e8268d"}}